The effect of Viola drop on dry eye

Phase 3

Recruiting

Conditions: Dry Eye Syndrome.
Tear film insufficiency, Meibomian gland dysfunction
H 04.1

Registration Number: IRCT20231013059708N1

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 52

Inclusion Criteria

Patients with complaints related to dry eye syndrome
OSDI questionnaire score is more than 12 and DEQ5 is more than 6
Consent to treatment with herbal and traditional medicines
No active eye infection
No history of refractive surgery
Absence of pterygium disease
Not using drugs with dry eye complications

Exclusion Criteria

The patient's unwillingness to receive treatment
Allergy to herbal medicines
Pregnancy
Breastfeeding

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dry Eye symptoms. Timepoint: Before the intervention, 2 weeks and 4 weeks after the intervention. Method of measurement: Completion of the OSDI and DEQ5 questionnaires.;Tear break time (TBUT). Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: The time of appearance of the first changes after the first blink in seconds with the keratograph.;Tear meniscus height. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: The height of the lacrimal crescent using the Keratograph values.;Redness of the conjunctiva. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: Using the Keratograph values.;Meibomian gland grade. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: Morphological changes of meibomian glands using the Keratograph values.

Secondary Outcome Measures